73 evolution "https:" "https:" "https:" "https:" "https:" "https:" "Dublin City University" PhD scholarships at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
PhD Position in Method Development for Peptide Ionization and Fragmentation_3590 Project Description We invite applications for a fully funded PhD position in experimental proteomics. The successful
-
ample opportunities for direct validation in biologically relevant settings. This interdisciplinary atmosphere has been a main catalyst for many past successes: https://europepmc.org/article/MED/35021063
-
well as basic research with the combined tools of immunology, microbiology, virology, cell biology and molecular biology. For more information, please see https://www.mhh.de/hbrs/zib MD/PhD Molecular Medicine:The
-
Smet ( https://desmetlab.sites.vib.be ) and F. Van Breusegem ( https://vanbreusegemlab.sites.vib.be ) have expertise in abiotic stress signaling and in advanced molecular profiling, including mass
-
, public authorities in their decisions and businesses in their strategies. Do you want to know more about LIST? Check our website: https://www.list.lu/ How will you contribute? You will develop a multi
-
development support. Qualifications Specific Requirements MSc in Pharmacy; Experience with amino acid transporters; Experience with pharmaceutical application of drug transporters; Strong motivation and
-
. Benefits and salary The successful candidates will receive an attractive salary in accordance with the MSCA regulations for Early-Stage Researchers (http://ec.europa.eu/research/mariecurieactions
-
LMU Munich. The group is located within the Institute of Clinical Neuroimmunology (https://www.neuroimmunology-munich.de/ ). The professorship of Systems Neuroimmunology is part of the Cluster
-
well as multifold training and support for PhD students in framework of ISAS and the Leibniz association Training and scientific development opportunities in an international environment and an excellent working
-
the development of scalable software tools and pipelines, potentially leveraging GPU/FPGA accelerators. Our aim is to build next-generation molecular atlases for chronic diseases and to improve patient